Cargando…
Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation
Objectives There has been a rapid increase in the number of one- and two-room proton beam therapy (PBT) centers, which may be limited in the number of patients they can treat. The objective of this study was to analyze the impact of the ‘clinical benefit score’ (CBS), utilized as a method for treatm...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823008/ https://www.ncbi.nlm.nih.gov/pubmed/31720171 http://dx.doi.org/10.7759/cureus.5703 |
_version_ | 1783464456276148224 |
---|---|
author | Sharma, Ankur M Khairnar, Rahul Kowalski, Emily S Remick, Jill Nichols, Elizabeth M Mohindra, Pranshu Yock, Torunn Regine, William Mishra, Mark V |
author_facet | Sharma, Ankur M Khairnar, Rahul Kowalski, Emily S Remick, Jill Nichols, Elizabeth M Mohindra, Pranshu Yock, Torunn Regine, William Mishra, Mark V |
author_sort | Sharma, Ankur M |
collection | PubMed |
description | Objectives There has been a rapid increase in the number of one- and two-room proton beam therapy (PBT) centers, which may be limited in the number of patients they can treat. The objective of this study was to analyze the impact of the ‘clinical benefit score’ (CBS), utilized as a method for treatment prioritization for PBT operating in a ‘cost-neutral’ proton-photon payer environment. Materials & methods This study includes patients considered for PBT at a center that initially had only one or two treatment rooms available for clinical use. Patients were prospectively scored using the CBS, and higher scores were prioritized. The outcome was receipt of PBT and the independent variable was CBS. Crude and adjusted analyses were performed using logistic regression. Results There were 2163 patients evaluated. A total of 205 patients (9.5%) were deemed candidates for PBT, which was received by 122 (5.6%) patients. In patients considered for PBT, the mean CBS was 18.7. Patients who were <21 years old, female, non-Caucasian, receiving re-irradiation, and those with Medicare had a higher CBS. Multivariate analysis adjusting for insurance status revealed both CBS and insurance to be significant predictors for receiving PBT. A unit increase in CBS was associated with 1.04 times increased odds of receiving PBT (OR=1.04, 95%CI: 1.01-1.07, p=0.0145) and having Medicare was associated with 3.13 times increased odds of receiving PBT (OR=3.13, 95%CI: 1.57-6.26, p=0.0012). Subgroup analysis, which only included patients enrolled prior to opening the second gantry, showed 1.05 times increased odds of receiving PBT per unit increase in CBS (OR=1.05, 95%CI: 1.00-1.10, p=0.03) and 2.87 times increased odds of receiving PBT in patients with Medicare (OR=2.87, 95%CI: 1.04-7.92, p=0.04). Conclusion The CBS utilized was significantly associated with the receipt of PBT in a cost-neutral payer setting. Physicians may consider the use of CBS as a resource allocation tool. |
format | Online Article Text |
id | pubmed-6823008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-68230082019-11-12 Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation Sharma, Ankur M Khairnar, Rahul Kowalski, Emily S Remick, Jill Nichols, Elizabeth M Mohindra, Pranshu Yock, Torunn Regine, William Mishra, Mark V Cureus Radiation Oncology Objectives There has been a rapid increase in the number of one- and two-room proton beam therapy (PBT) centers, which may be limited in the number of patients they can treat. The objective of this study was to analyze the impact of the ‘clinical benefit score’ (CBS), utilized as a method for treatment prioritization for PBT operating in a ‘cost-neutral’ proton-photon payer environment. Materials & methods This study includes patients considered for PBT at a center that initially had only one or two treatment rooms available for clinical use. Patients were prospectively scored using the CBS, and higher scores were prioritized. The outcome was receipt of PBT and the independent variable was CBS. Crude and adjusted analyses were performed using logistic regression. Results There were 2163 patients evaluated. A total of 205 patients (9.5%) were deemed candidates for PBT, which was received by 122 (5.6%) patients. In patients considered for PBT, the mean CBS was 18.7. Patients who were <21 years old, female, non-Caucasian, receiving re-irradiation, and those with Medicare had a higher CBS. Multivariate analysis adjusting for insurance status revealed both CBS and insurance to be significant predictors for receiving PBT. A unit increase in CBS was associated with 1.04 times increased odds of receiving PBT (OR=1.04, 95%CI: 1.01-1.07, p=0.0145) and having Medicare was associated with 3.13 times increased odds of receiving PBT (OR=3.13, 95%CI: 1.57-6.26, p=0.0012). Subgroup analysis, which only included patients enrolled prior to opening the second gantry, showed 1.05 times increased odds of receiving PBT per unit increase in CBS (OR=1.05, 95%CI: 1.00-1.10, p=0.03) and 2.87 times increased odds of receiving PBT in patients with Medicare (OR=2.87, 95%CI: 1.04-7.92, p=0.04). Conclusion The CBS utilized was significantly associated with the receipt of PBT in a cost-neutral payer setting. Physicians may consider the use of CBS as a resource allocation tool. Cureus 2019-09-19 /pmc/articles/PMC6823008/ /pubmed/31720171 http://dx.doi.org/10.7759/cureus.5703 Text en Copyright © 2019, Sharma et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Radiation Oncology Sharma, Ankur M Khairnar, Rahul Kowalski, Emily S Remick, Jill Nichols, Elizabeth M Mohindra, Pranshu Yock, Torunn Regine, William Mishra, Mark V Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation |
title | Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation |
title_full | Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation |
title_fullStr | Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation |
title_full_unstemmed | Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation |
title_short | Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation |
title_sort | patient prioritization for proton beam therapy in a cost-neutral payer environment: use of the clinical benefit score for resource allocation |
topic | Radiation Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823008/ https://www.ncbi.nlm.nih.gov/pubmed/31720171 http://dx.doi.org/10.7759/cureus.5703 |
work_keys_str_mv | AT sharmaankurm patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation AT khairnarrahul patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation AT kowalskiemilys patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation AT remickjill patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation AT nicholselizabethm patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation AT mohindrapranshu patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation AT yocktorunn patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation AT reginewilliam patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation AT mishramarkv patientprioritizationforprotonbeamtherapyinacostneutralpayerenvironmentuseoftheclinicalbenefitscoreforresourceallocation |